Skip to main content
Premium Trial:

Request an Annual Quote

NIH Launches Program to Study Genetics and Genomics of Xenopus

NEW YORK, Sept. 26 (GenomeWeb News) - The National Institutes of Health has announced a new program entitled, "Genetic and Genomic Analyses of Xenopus," which is seeking new genetic and genomic tools "to exploit the power of Xenopus as a vertebrate model for biomedical research."


According to a program announcement issued last week, the NIH welcomes proposals "to develop new tools or genetic or genomic resources of high priority to the Xenopus community that will advance the detection and characterization of genes, pathways, and phenotypes of interest in development, organogenesis, and in cell biological processes, such as cell division, signaling and migration."


In the program announcement, NIH outlined a number or resources that have already been developed for X. tropicalis and X. laevis, including cDNA libraries and EST sequences, UniGene clusters, full-insert cDNA clones and sequences, a genetic map, genomic libraries and genomic sequences, a physical map, microarrays, and transgenic and mutant animals. "These diverse data and reagents are being generated by investigators from several different research communities, including geneticists, gene sequencers, gene mappers, cell biologists, developmental biologists, and bioinformatics experts," NIH said, and  "can now be used to enhance Xenopus' role as a model system."


NIH said that it has not set aside any special funding for applications submitted in response to the announcement.


The anticipated start dates for new awards will be December, 2007, 2008, and 2009.


The first due date for letters of intent is Dec. 19, and the first due date for applications is Jan. 18, 2006.


"Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary," NIH said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.